PRISM Mid-Day Movers: Biotech Longevity Hopes and Weight Loss Funding Drive Market Action

PRISM MarketView
Monday, June 9, 2025 at 4:36pm UTC

Klotho Neurosciences Soars 568% on Longevity Gene Study
Klotho Neurosciences, Inc. (KLTO) rocketed over 568% to lead the PRISM Emerging Biotech Index after unveiling promising pre-clinical data focused on the Klotho gene, a factor long associated with lifespan and age-related degeneration. In a newly published paper, the secreted Klotho protein, administered via an AAV9 vector, extended mouse lifespans by 20%. KLTO holds exclusive global rights for s-KL as a potential therapy for age-related and neurodegenerative conditions like Alzheimer’s and ALS, potentially opening the door to a new class of treatments aimed at extending both life and health span.

ReShape Lifesciences Tumbles 42% After Announcing $2.6M Offering
ReShape Lifesciences Inc. (RSLS) sank 42% within the PRISM Emerging Weight Loss Index after announcing a $2.6 million public stock offering priced at $2.50 per share. The company’s portfolio includes the Lap-Band® system and Obalon® balloon technology for minimally invasive obesity treatments.

Other PRISM Mid-Day Movers:

  • Helius Medical Technologies, Inc. (HSDT) down 22.19%
  • Fractyl Health Inc. (GUTS) up 17.59%
  • Alarum Technologies Ltd. (ALAR) up 34.65%

The post PRISM Mid-Day Movers: Biotech Longevity Hopes and Weight Loss Funding Drive Market Action appeared first on PRISM MarketView.